J&J launches satellite research centre with UCT’s drug discovery unit
25 April 2022 - 18:39
US pharmaceutical manufacturer Johnson & Johnson (J&J) has launched a new satellite research site at the University of Cape Town’s (UCT’s) Holistic Drug Discovery and Development (H3D) Centre, that aims to devise new treatments for drug-resistant pathogens.
Drug resistance arises when bacteria, fungi or viruses mutate and develop the ability to evade the treatments designed to kill them...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.